RARE
Ultragenyx Pharm (RARE)
NASDAQ
$33.53+$0.30 (+0.92%)
Price as of Jul 14, 2026 4:50 AM EDT
  • $3.3B
    Market Cap
  • 13.65%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 39
Valuation
RARE
vs History
vs S&P 500
Profitability
-0
Growth
-1
Low Earnings Volatility
3

Momentum Score

Score: 57
Valuation
RARE
vs History
vs S&P 500
3-Month Momentum
-0.78%
12-Month Momentum
-22.16%
3-Month Risk Adjusted Momentum
-4.10%
12-Month Risk Adjusted Momentum
-34.38%

True Yield

N/A
Valuation
RARE
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.08%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 45
Valuation
RARE
vs History
vs S&P 500
Ohlson's O-Score
6